Swiss registry for TNF-α blockers in children and adolescents with rheumatological diseases;Schweizerisches register für TNF-α-blocker bei kindern und jugendlichen mit rheumatologischen erkrankungen

Praxis

Volumn 99, Issue 11, 2010, Pages 649-654

  Sauvain, M J ^a   Schalm, S B ^a   Berthet G ^b   Bolz, D ^c   Cannizzaro, E ^d   Hofer, M ^e   Kaiser, D ^f   Saurenmann, R K ^d   Bolt, Isabel ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^f LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

Anti TNF therapy; Idiopathic uveitis; Juvenile idiopathic arthritis

Indexed keywords

CORTICOSTEROID; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TUMOR NECROSIS FACTOR INHIBITOR;

ADOLESCENT; ARTICLE; CHILD; DISEASE ACTIVITY; DISEASE REGISTRY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATIC DISEASE; SWITZERLAND; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 77953004469     PISSN: 16618157     EISSN: 16618165     Source Type: Journal    
DOI: 10.1024/1661-8157/a000144     Document Type: Article

References (16)

1. Gartlehner G, Hansen RA, Jonas BL, Thieda P, Lohr KN. Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence. Clin Rheumatol 2008; 27: 67-76. (Pubitemid 350182680)
2. Gerloni V, Pontikaki I, Gattinara M, Fantini F. [Biological therapy with TNF-inhibitors in pediatric rheumatology. Review of the literature and personal experience]. Reumatismo 2007; 59: 244-261.
3. Ruperto N, Lovell DJ, Cuttica R, Wilkinson N, Woo P, Espada G, et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. Arthritis Rheum 2007; 56: 3096-3106. (Pubitemid 47502757)
4. Biester S, Deuter C, Michels H, Haefner R, Kuemmerle-Deschner J, Doycheva D, et al. Adalimumab in the therapy of uveitis in childhood. Br J Ophthalmol 2007; 91: 319-324. (Pubitemid 46586527)
5. Bolt IB, Cannizzaro E, Seger R, Saurenmann RK. Risk factors and longterm outcome of juvenile idiopathic arthritis-associated uveitis in Switzerland. J Rheumatol 2008; 35: 703-706. (Pubitemid 351500070)
6. Foeldvari I, Nielsen S, Kummerle-Deschner J, Espada G, Horneff G, Bica B, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 2007; 34: 1146-1150. (Pubitemid 46774863)
7. Heiligenhaus A, Horneff G, Greiner K, Mackensen F, Zierhut M, Foeldvari I, et al. [Inhibitors of tumour necrosis factor-alpha for the treatment of arthritis and uveitis in childhood]. Klin Monatsbl Augenheilkd 2007; 224: 526-531.
8. Petropoulos IK, Vaudaux JD, Guex-Crosier Y. Anti-TNF-alpha therapy in patients with chronic non-infectious uveitis: the experience of Jules Gonin Eye Hospital. Klin Monatsbl Augenheilkd 2008; 225: 457-461. (Pubitemid 352016484)
9. Tynjala P, Kotaniemi K, Lindahl P, Latva K, Aalto K, Honkanen V, et al. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology (Oxford) 2008; 47: 339-344. (Pubitemid 351267203)
10. Vazquez-Cobian LB, Flynn T, Lehman TJ. Adalimumab therapy for childhood uveitis. J Pediatr 2006; 149: 572-575. (Pubitemid 44468085)
11. Ravelli A, Martini A. Remission in juvenile idiopathic arthritis. Clin Exp Rheumatol 2006; 24(Suppl: S105-S110.
12. Wallace CA, Ruperto N, Giannini E. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. J Rheumatol 2004; 31: 2290-2294. (Pubitemid 39453253)
13. Horneff G, Schmeling H, Biedermann T, Foeldvari I, Ganser G, Girschick HJ, et al. The German etanercept registry for treatment of juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 1638-1644. (Pubitemid 39573695)
14. Horneff G, De Bock F, Foeldvari I, Girschick HJ, Michels H, Moebius D, et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry. Ann Rheum Dis 2009; 68: 519-525.
15. Prince FH, Twilt M, ten Cate R, van Rossum MA, Armbrust W, Hoppenreijs EP, et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register. Ann Rheum Dis 2009; 68: 635-641.
16. Horneff G. [Importance of the new biologicals and cytokine antagonists in the treatment of juvenile idiopathic arthritis (JIA)]. Z Rheumatol 2005; 64: 317-326.